ReviewNature communications2026
Synthetic rewriting technologies in mammalian cells.
Review in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic rewriting technologies, encompassing large-scale DNA assembly, transfer, maintenance, and rearrangement, enabled de novo synthesis or large-scale modifications of genomes. While significant progress has been made in model organisms of viruses, bacteria, and unicellular eukaryotes, their development in mammalian cells faces unique challenges. This review summarizes key breakthroughs in synthetic rewriting technologies, including megabase (Mb)-scale assembly of human DNA, yeast-mediated transfer methods, bottom-up human artificial chromosomes (HACs), and genome-scale rearrangement, along with emerging applications in constructing models and decoding genomes for mammals. These tools will expand functional engineering in mammals and deepen mechanistic insights into complex biological systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.